Testing effectiveness (Phase 2)Study completedNCT00005056What this trial is testingBryostatin 1 In Treating Patients With Progressive Kidney CancerWho this might be right forKidney Cancer Cancer Research UK
Large-scale testing (Phase 3)Study completedNCT00002473What this trial is testingKidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney CancerWho this might be right forKidney Cancer European Organisation for Research and Treatment of Cancer - EORTC
Very early researchStudy completedNCT00405366What this trial is testingSorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney CancerWho this might be right forKidney Cancer UNC Lineberger Comprehensive Cancer Center 30
Early research (Phase 1)WithdrawnNCT06626256What this trial is testingSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWho this might be right forLocally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more City of Hope Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012371What this trial is testingLenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell CancerWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Looking for participantsNCT04473781What this trial is testingInterstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney CancerWho this might be right forStage I Renal Cell CancerStage II Renal Cell Cancer Jonsson Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)Ended earlyNCT04370509What this trial is testingPembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing SurgeryWho this might be right forMetastatic Clear Cell Renal Cell CarcinomaRecurrent Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+2 more University of California, San Francisco 6
Testing effectiveness (Phase 2)Looking for participantsNCT06447103What this trial is testingAn Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer+2 more Jonsson Comprehensive Cancer Center 91
Not applicableEnded earlyNCT00727532What this trial is testingSorafenib in Treating Patients With Locally Advanced or Metastatic Kidney CancerWho this might be right forHereditary Clear Cell Renal Cell CarcinomaKidney Cancer Northwestern University 9
Testing effectiveness (Phase 2)Ended earlyNCT03334409What this trial is testingPazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by SurgeryWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+2 more Academic and Community Cancer Research United 5
Early research (Phase 1)Ended earlyNCT02595918What this trial is testingNivolumab in Treating Patients With High-Risk Kidney Cancer Before SurgeryWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7+3 more National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Looking for participantsNCT06661720What this trial is testingTesting the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRenal Cell Carcinoma (RCC)Stage II Renal Pelvis Cancer AJCC v8+1 more Alliance for Clinical Trials in Oncology 1,040
Not applicableWithdrawnNCT01769885What this trial is testingTivozanib Before Surgery in Treating Patients With Localized Kidney CancerWho this might be right forStage II Renal Cell CancerStage III Renal Cell Cancer Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT06265285What this trial is testingComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramWho this might be right forAdvanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more Mayo Clinic 50
Testing effectiveness (Phase 2)WithdrawnNCT05564416What this trial is testingTesting Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA TrialWho this might be right forBladder CarcinomaBladder Urothelial CarcinomaMuscle Invasive Bladder Carcinoma+5 more National Cancer Institute (NCI)
Not applicableStudy completedNCT00458484What this trial is testingRadiosurgery in Treating Patients With Kidney TumorsWho this might be right forKidney Cancer Case Comprehensive Cancer Center 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07037004What this trial is testingAdding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After SurgeryWho this might be right forClear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more City of Hope Medical Center 62
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+127 more Mayo Clinic 36
Very early researchStudy completedNCT00436410What this trial is testingTumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerWho this might be right forAdrenocortical CarcinomaBreast CancerColorectal Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT04645680What this trial is testingDiet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving ImmunotherapyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+7 more M.D. Anderson Cancer Center 50